对COPD患者在急性恶化期间不同肺功能时的支气管洗液微生物群的分析
Kawsar Bahetjan1, Yu-Xia2, Shijun Lin1
1Respiratory and Respiratory Critical Care Center, School of Medicine, The Second Affiliated Hospital, The Chinese University of Hong Kong, Shenzhen, 518172, China.
Scientific reports
|April 16, 2025
概括
慢性阻塞性肺病 (COPD) 患者严重肺功能下降显示呼吸道微生物多样性减少. 像Corynebacterium这样的特定细菌在严重的COPD中增加,提供潜在的治疗点.
科学领域:
- 肺部医学 肺部医学
- 微生物学 微生物学
- 基因组学就是基因组学.
背景情况:
- 呼吸系统微生物群失调与慢性阻塞性肺病 (COPD) 的发生,严重程度和死亡率有关.
- 支气管支气管洗液 (BALF) 微生物群与COPD患者的肺功能之间的关系需要进一步澄清.
研究的目的:
- 研究COPD患者在BALF微生物组合中的差异,COPD患者的肺功能和恶化频率各不相同.
- 确定与严重空气流限制和COPD急性恶化的频繁恶化相关的特定微生物种群 (AECOPD).
主要方法:
- 从70名AECOPD患者收集了BALF样本,按肺功能 (轻度PFT I与严重PFT II) 和恶化史 (频繁的FE与不频繁的NFE) 分类.
- 使用下一代测序 (mNGS) 和生物信息分析进行微生物群分析.
- 利用统计方法,包括香农多样性,Chao1,ACE指数和斯皮尔曼相关性分析.
主要成果:
- 严重的肺功能 (PFT II) 与轻度的肺功能 (PFT I) 相比,与显著减少的物种多样性 (香农指数) 和丰富性 (Chao1,ACE指数) 相关.
- 观察到不同的微生物概况:Corynebacterium,Moraxella,Fusobacterium,Haemophilus,Streptomyces和Klebsiella在严重组 (PFT II) 中得到了丰富.
- 频繁恶化 (FE) 组显示Streptococcus mitis的丰度增加,而非频繁恶化 (NFE) 组的相对丰度较高. 细菌类和Prevotella.
结论:
- 在AECOPD患者之间存在BALF微生物组成的显著变化,患者的肺功能水平和恶化频率不同.
- 在AECOPD中,严重的空气流限制的特点是微生物多样性减少和特定细菌种群的丰富.
- 这些发现凸显了微生物群在AECOPD病变发生过程中的潜在作用,并提出了新的治疗干预措施的目标.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.4K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
123
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
123
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:26Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture
134
Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
134
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K